2023
DOI: 10.4103/1673-5374.355751
|View full text |Cite
|
Sign up to set email alerts
|

Molecular hallmarks of long non-coding RNAs in aging and its significant effect on aging-associated diseases

Abstract: Aging is linked to the deterioration of many physical and cognitive abilities and is the leading risk factor for Alzheimer’s disease. The growing aging population is a significant healthcare problem globally that researchers must investigate to better understand the underlying aging processes. Advances in microarrays and sequencing techniques have resulted in deeper analyses of diverse essential genomes (e.g., mouse, human, and rat) and their corresponding cell types, their organ-specific transcriptomes, and t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 206 publications
0
8
0
Order By: Relevance
“…Another candidate hallmark supported by several studies is the dysregulation of RNA processing, a process that regulates gene expression ( Figure 4 ). This hallmark was first proposed in the Copenhagen aging meeting in 2022 ( Schmauck-Medina et al, 2022 ) and then supported by other studies that highlighted the relevance of long non-coding RNAs ( Sherazi et al, 2023 ) and RNA binding proteins ( Varesi et al, 2023 ) in the aging process. These works pointed out that these elements lose their regulation during aging and how the subsequent molecular and cellular changes promote the aging process and its associated diseases ( Sherazi et al, 2023 ; Varesi et al, 2023 ).…”
Section: Introductionmentioning
confidence: 70%
“…Another candidate hallmark supported by several studies is the dysregulation of RNA processing, a process that regulates gene expression ( Figure 4 ). This hallmark was first proposed in the Copenhagen aging meeting in 2022 ( Schmauck-Medina et al, 2022 ) and then supported by other studies that highlighted the relevance of long non-coding RNAs ( Sherazi et al, 2023 ) and RNA binding proteins ( Varesi et al, 2023 ) in the aging process. These works pointed out that these elements lose their regulation during aging and how the subsequent molecular and cellular changes promote the aging process and its associated diseases ( Sherazi et al, 2023 ; Varesi et al, 2023 ).…”
Section: Introductionmentioning
confidence: 70%
“…124 Therefore, lncRNAs may affect several cellular processes, including cellular proliferation, differentiation, senescence, quiescence, and response to stress and immune agents. 125…”
Section: Lncrnamentioning
confidence: 99%
“…LncRNAs are expressed during cell differentiation and development which makes them capable of regulating the cell cycle, DNA replication timing and chromosome stability, genetic imprinting, stem cell reprogramming, chromatin remodeling, gene transcription, mRNA stability, translation, and protein stability 124 . Therefore, lncRNAs may affect several cellular processes, including cellular proliferation, differentiation, senescence, quiescence, and response to stress and immune agents 125 …”
Section: Noncoding (Nc) Rnas and Immunosenescencementioning
confidence: 99%
“…In recent years, lncRNAs were particularly studied for their role in the regulation of transcription and translation in physiological conditions and disease. Since lncRNA are particularly expressed and conserved in the brain (Ponjavic et al, 2009;Chodroff et al, 2010;Barry, 2014;Yang et al, 2021;Kyzar et al, 2022), their role was investigated in the epigenetic adaption of gene expression in drug addiction, aging, neuroinflammation, brain injury, neurodegenerative and neurodevelopmental diseases (Wang et al, 2018;Srivastava et al, 2021;Sivagurunathan et al, 2022;Yang K. et al, 2022;Mazzeo et al, 2023;Ruffo et al, 2023;Sherazi et al, 2023). The expression rate of lncRNAs is epigenetically modulated.…”
Section: Lncrna In α-Synucleinopathiesmentioning
confidence: 99%